INS and Insulin resistance: While insulin remained within the reference interval (12–96 ​pmol/L (Amsterdam UMC)) and is not of clinical significance on its own, alongside reductions in fasting blood glucose and HbA1c, the decrease supports the intervention's effect on reducing insulin resistance.